These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24322389)
1. Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors. Tan W; Mei H; Chao L; Liu T; Pan X; Shu M; Yang L J Comput Aided Mol Des; 2013 Dec; 27(12):1067-73. PubMed ID: 24322389 [TBL] [Abstract][Full Text] [Related]
3. Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein. Bikadi Z; Hazai I; Malik D; Jemnitz K; Veres Z; Hari P; Ni Z; Loo TW; Clarke DM; Hazai E; Mao Q PLoS One; 2011; 6(10):e25815. PubMed ID: 21991360 [TBL] [Abstract][Full Text] [Related]
4. 2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein. Jabeen I; Wetwitayaklung P; Chiba P; Pastor M; Ecker GF J Comput Aided Mol Des; 2013 Feb; 27(2):161-71. PubMed ID: 23400406 [TBL] [Abstract][Full Text] [Related]
5. Image-based QSAR Model for the Prediction of P-gp Inhibitory Activity of Epigallocatechin and Gallocatechin Derivatives. Ghaemian P; Shayanfar A Curr Comput Aided Drug Des; 2019; 15(3):212-224. PubMed ID: 30280673 [TBL] [Abstract][Full Text] [Related]
6. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058 [TBL] [Abstract][Full Text] [Related]
8. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors. Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857 [TBL] [Abstract][Full Text] [Related]
9. Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein. Chang YT; Lin YC; Sun L; Liao WC; Wang CCN; Chou CY; Morris-Natschke SL; Lee KH; Hung CC Phytomedicine; 2020 Jun; 71():153239. PubMed ID: 32447245 [TBL] [Abstract][Full Text] [Related]
10. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent. Mollazadeh S; Shamsara J; Iman M; Hadizadeh F Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors. Wang RB; Kuo CL; Lien LL; Lien EJ J Clin Pharm Ther; 2003 Jun; 28(3):203-28. PubMed ID: 12795780 [TBL] [Abstract][Full Text] [Related]
12. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors. Qu D; Yan A; Zhang JS SAR QSAR Environ Res; 2017 Feb; 28(2):111-132. PubMed ID: 28235391 [TBL] [Abstract][Full Text] [Related]
13. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082 [TBL] [Abstract][Full Text] [Related]
14. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188 [TBL] [Abstract][Full Text] [Related]
15. Potential drug candidates as P-glycoprotein inhibitors to reverse multidrug resistance in cancer: an Ibrahim MAA; Abdeljawaad KAA; Jaragh-Alhadad LA; Oraby HF; Atia MAM; Alzahrani OR; Mekhemer GAH; Moustafa MF; Shawky AM; Sidhom PA; Abdelrahman AHM J Biomol Struct Dyn; 2023; 41(23):13977-13992. PubMed ID: 36883864 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions. Cao Y; Shi Y; Cai Y; Hong Z; Chai Y Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867 [TBL] [Abstract][Full Text] [Related]
17. The Differential Absorption of a Series of P-Glycoprotein Substrates in Isolated Perfused Lungs from Mdr1a/1b Genetic Knockout Mice can be Attributed to Distinct Physico-Chemical Properties: an Insight into Predicting Transporter-Mediated, Pulmonary Specific Disposition. Price DF; Luscombe CN; Eddershaw PJ; Edwards CD; Gumbleton M Pharm Res; 2017 Dec; 34(12):2498-2516. PubMed ID: 28702798 [TBL] [Abstract][Full Text] [Related]
18. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420 [TBL] [Abstract][Full Text] [Related]
19. Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme. Leong MK; Chen HB; Shih YH PLoS One; 2012; 7(3):e33829. PubMed ID: 22439003 [TBL] [Abstract][Full Text] [Related]
20. Designing potent inhibitors against the multidrug resistance P-glycoprotein. Mahmud S; Islam MJ; Parves MR; Khan MA; Tabussum L; Ahmed S; Ali MA; Fakayode SO; Halim MA J Biomol Struct Dyn; 2022; 40(19):9403-9415. PubMed ID: 34060432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]